Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 59.40
+1.60 (2.77%)
Jun 5, 2026, 5:35 PM CET
Clínica Baviera Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 42.06 | 40.21 | 35.97 | 29.52 | 27.39 |
Depreciation & Amortization | 22.13 | 19.98 | 16.46 | 14.8 | 13.89 |
Other Amortization | 1.76 | 0.9 | 0.52 | 0.2 | 0.2 |
Asset Writedown & Restructuring Costs | 0.1 | -0.03 | 0.03 | 0.47 | 0.03 |
Loss (Gain) From Sale of Investments | -0.37 | -1.22 | - | - | - |
Provision & Write-off of Bad Debts | 0.18 | 0.06 | -0.02 | 0.18 | 0.06 |
Other Operating Activities | 2.69 | 4.41 | 3.09 | 3.25 | 1.44 |
Change in Accounts Receivable | 0.28 | 0.22 | -0.43 | 0.18 | -0.91 |
Change in Inventory | -0.04 | -0.25 | -0.31 | -0.23 | -0.29 |
Change in Accounts Payable | 8.05 | -1.78 | 2.5 | 5.02 | 5.04 |
Operating Cash Flow | 76.84 | 62.51 | 57.81 | 53.38 | 46.86 |
Operating Cash Flow Growth | 22.93% | 8.12% | 8.31% | 13.92% | 48.96% |
Capital Expenditures | -30.01 | -26.51 | -22.68 | -14.03 | -10.58 |
Cash Acquisitions | -0.92 | -11.11 | - | - | -0.05 |
Divestitures | 20.34 | 30.58 | - | - | - |
Investment in Securities | -35.95 | -14.16 | -21.79 | 1.4 | -6.46 |
Other Investing Activities | 1.52 | 0.3 | 0.15 | 0.07 | 0 |
Investing Cash Flow | -45.02 | -20.9 | -44.31 | -12.56 | -17.08 |
Long-Term Debt Issued | 3 | 7.2 | - | - | 0.08 |
Long-Term Debt Repaid | -12.86 | -11.79 | -10.52 | -13.69 | -13.43 |
Net Debt Issued (Repaid) | -9.86 | -4.59 | -10.52 | -13.69 | -13.35 |
Issuance of Common Stock | 3.16 | 1.43 | 0.71 | 0.6 | 0.5 |
Repurchase of Common Stock | -2.39 | -10.24 | -0.71 | -0.62 | -0.49 |
Common Dividends Paid | -25.13 | -25.09 | -13.04 | -16.79 | -17.15 |
Other Financing Activities | -2.24 | -1.17 | -0.81 | -0.95 | -0.31 |
Financing Cash Flow | -36.45 | -39.66 | -24.37 | -31.45 | -30.8 |
Foreign Exchange Rate Adjustments | 0.08 | -0.12 | - | - | - |
Net Cash Flow | -4.55 | 1.83 | -10.87 | 9.37 | -1.02 |
Free Cash Flow | 46.83 | 36 | 35.13 | 39.35 | 36.28 |
Free Cash Flow Growth | 30.08% | 2.46% | -10.71% | 8.45% | 53.50% |
Free Cash Flow Margin | 15.36% | 13.55% | 15.47% | 19.83% | 20.94% |
Free Cash Flow Per Share | 2.92 | 2.25 | 2.15 | 2.41 | 2.23 |
Cash Interest Paid | 0.69 | 0.18 | 0.11 | 0.46 | 0.11 |
Cash Income Tax Paid | 17.33 | 13.08 | 11.64 | 9.63 | 11.28 |
Levered Free Cash Flow | 40.45 | 30.98 | 26.81 | 33.33 | 31.68 |
Unlevered Free Cash Flow | 41.88 | 31.74 | 27.16 | 33.59 | 31.96 |
Change in Working Capital | 8.29 | -1.81 | 1.76 | 4.96 | 3.84 |